During my meeting with Prof. Dr. Manfred Wildner and his colleague Dr. Herbert Zöllner in Munich, Germany, we discussed the comparative advantages and disadvantages of the German, UK, and US public health systems. The systems are strikingly different.
On the preparedness front in the United States, the new National Biodefense Strategy was released on September 19, 2018. The new strategy establishes clear and thoughtful goals that will become a vital part of “managing the risk of biological incidents… in today’s interconnected world” 1. Continue Reading